Ikarian Capital’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-221,911
| Closed | -$1.48M | – | 144 |
|
|
2025
Q1 | $1.48M | Hold |
221,911
| – | – | 0.18% | 51 |
|
|
2024
Q4 | $2.79M | Buy |
221,911
+24,815
| +13% | +$312K | 0.38% | 37 |
|
|
2024
Q3 | $3.64M | Hold |
197,096
| – | – | 0.51% | 30 |
|
|
2024
Q2 | $4.24M | Sell |
197,096
-100,000
| -34% | -$2.15M | 0.74% | 20 |
|
|
2024
Q1 | $8M | Buy |
297,096
+57,370
| +24% | +$1.55M | 0.88% | 15 |
|
|
2023
Q4 | $7.18M | Sell |
239,726
-415,000
| -63% | -$12.4M | 0.67% | 19 |
|
|
2023
Q3 | $13.4M | Buy |
+654,726
| New | +$13.4M | 1.61% | 4 |
|
|
2021
Q2 | – | Sell |
-1,400
| Closed | -$61K | – | 208 |
|
|
2021
Q1 | $61K | Hold |
1,400
| – | – | ﹤0.01% | 171 |
|
|
2020
Q4 | $75K | Buy |
+1,400
| New | +$75K | ﹤0.01% | 124 |
|